Prion Diseases: What Is the Neurotoxic Molecule?

A great deal of effort has been devoted during the past 20 years to defining the chemical nature of prions, the infectious agents responsible for transmissible spongiform encephalopathies. In contrast, much less attention has been paid to elucidating how prions actually damage the central nervous system. Although it is commonly assumed that PrP(Sc), the protein constituent of infectious prions, is the primary culprit, increasing evidence indicates that this may not be the case. Several alternative molecular forms of PrP are reasonable candidates for the neurotoxic species in prion diseases, although it is still too early to tell whether these or other ones will turn out to be the true instigating factors. The cellular pathways activated by neurotoxic forms of PrP that ultimately result in neuronal death are also being investigated, and several possible mechanisms have been uncovered, including the operation of quality control processes in the endoplasmic reticulum. Elucidating the distinction between the infectious and neurotoxic forms of PrP has important implications for designing therapy of prion diseases, as well as for understanding pathogenic mechanisms operative in other neurodegenerative disorders and the role of prion-like states in biology.

[1]  Terrance T. Kummer,et al.  Mutant Prion Proteins Are Partially Retained in the Endoplasmic Reticulum* , 2001, The Journal of Biological Chemistry.

[2]  R. Hegde,et al.  Combinatorial Control of Prion Protein Biogenesis by the Signal Sequence and Transmembrane Domain* , 2001, The Journal of Biological Chemistry.

[3]  J. Collinge,et al.  Location and properties of metal-binding sites on the human prion protein , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[4]  R. Glockshuber,et al.  Electron paramagnetic resonance evidence for binding of Cu(2+) to the C-terminal domain of the murine prion protein. , 2001, Biophysical journal.

[5]  B. Ghetti,et al.  Prion proteins with different conformations accumulate in Gerstmann-Sträussler-Scheinker disease caused by A117V and F198S mutations. , 2001, The American journal of pathology.

[6]  S. Hornemann,et al.  Prion Protein Binds Copper within the Physiological Concentration Range* , 2001, The Journal of Biological Chemistry.

[7]  W. Surewicz,et al.  On the Mechanism of α-Helix to β-Sheet Transition in the Recombinant Prion Protein† , 2001 .

[8]  S. Prusiner,et al.  Shattuck lecture--neurodegenerative diseases and prions. , 2001, The New England journal of medicine.

[9]  B. Dobberstein,et al.  Prion Protein Contains a Second Endoplasmic Reticulum Targeting Signal Sequence Located at Its C Terminus* , 2001, The Journal of Biological Chemistry.

[10]  N. Hooper,et al.  Ablation of the metal ion-induced endocytosis of the prion protein by disease-associated mutation of the octarepeat region , 2001, Current Biology.

[11]  R. S. Stewart,et al.  A transmembrane form of the prion protein contains an uncleaved signal peptide and is retained in the endoplasmic Reticulum. , 2001, Molecular biology of the cell.

[12]  B. Caughey,et al.  Interactions between prion protein isoforms: the kiss of death? , 2001, Trends in biochemical sciences.

[13]  A. Pestronk,et al.  Primary Myopathy and Accumulation of PrPSc-Like Molecules in Peripheral Tissues of Transgenic Mice Expressing a Prion Protein Insertional Mutation , 2001, Neurobiology of Disease.

[14]  C. Masters,et al.  Sublethal Concentrations of Prion Peptide PrP106–126 or the Amyloid Beta Peptide of Alzheimer's Disease Activates Expression of Proapoptotic Markers in Primary Cortical Neurons , 2001, Neurobiology of Disease.

[15]  F. Cohen,et al.  A Protease-Resistant 61-Residue Prion Peptide Causes Neurodegeneration in Transgenic Mice , 2001, Molecular and Cellular Biology.

[16]  H. Kretzschmar,et al.  Prion Protein Affects Ca2+-Activated K+ Currents in Cerebellar Purkinje Cells , 2001, Neurobiology of Disease.

[17]  A. Negro,et al.  The Metabolism and Imaging in Live Cells of the Bovine Prion Protein in Its Native Form or Carrying Single Amino Acid Substitutions , 2001, Molecular and Cellular Neuroscience.

[18]  B. Ghetti,et al.  A 7-kDa Prion Protein (PrP) Fragment, an Integral Component of the PrP Region Required for Infectivity, Is the Major Amyloid Protein in Gerstmann-Sträussler-Scheinker Disease A117V* , 2001, The Journal of Biological Chemistry.

[19]  A. Aguzzi,et al.  Onset of ataxia and Purkinje cell loss in PrP null mice inversely correlated with Dpl level in brain , 2001, The EMBO journal.

[20]  David R. Brown Prion and prejudice: normal protein and the synapse , 2001, Trends in Neurosciences.

[21]  A. Goldberg,et al.  Cellular Defenses against Unfolded Proteins A Cell Biologist Thinks about Neurodegenerative Diseases , 2001, Neuron.

[22]  S. Prusiner,et al.  Structural Intermediates in the Putative Pathway from the Cellular Prion Protein to the Pathogenic Form , 2001, Biological chemistry.

[23]  R. S. Stewart,et al.  Most Pathogenic Mutations Do Not Alter the Membrane Topology of the Prion Protein* , 2001, The Journal of Biological Chemistry.

[24]  F. Cohen,et al.  Affinity-Tagged Miniprion Derivatives Spontaneously Adopt Protease-Resistant Conformations , 2000, Journal of Virology.

[25]  Arunandan Kumar,et al.  The Chaperone Protein BiP Binds to a Mutant Prion Protein and Mediates Its Degradation by the Proteasome* , 2000, The Journal of Biological Chemistry.

[26]  A. Favier,et al.  Prion infection impairs the cellular response to oxidative stress. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[27]  F. Cohen,et al.  Identification of the Cu2+ binding sites in the N-terminal domain of the prion protein by EPR and CD spectroscopy. , 2000, Biochemistry.

[28]  H. True,et al.  A yeast prion provides a mechanism for genetic variation and phenotypic diversity , 2000, Nature.

[29]  P. Lantos,et al.  Species-barrier-independent prion replication in apparently resistant species. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Sy,et al.  Prion disease: A loss of antioxidant function? , 2000, Biochemical and biophysical research communications.

[31]  G. Forloni,et al.  Apoptotic Cell Death and Impairment of L-Type Voltage-Sensitive Calcium Channel Activity in Rat Cerebellar Granule Cells Treated with the Prion Protein Fragment 106–126 , 2000, Neurobiology of Disease.

[32]  H. Budka,et al.  Evidence for Oxidative Stress in Experimental Prion Disease , 2000, Neurobiology of Disease.

[33]  C. V. Mering,et al.  Prion Protein Devoid of the Octapeptide Repeat Region Restores Susceptibility to Scrapie in PrP Knockout Mice , 2000, Neuron.

[34]  M. Sy,et al.  Effect of the E200K mutation on prion protein metabolism. Comparative study of a cell model and human brain. , 2000, The American journal of pathology.

[35]  G. Forloni,et al.  Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro. , 2000, Journal of molecular biology.

[36]  D. Harris,et al.  Nerve Growth Factor‐Induced Differentiation Does Not Alter the Biochemical Properties of a Mutant Prion Protein Expressed in PC12 Cells , 2000, Journal of neurochemistry.

[37]  B. Ghetti,et al.  Accumulation of protease-resistant prion protein (PrP) and apoptosis of cerebellar granule cells in transgenic mice expressing a PrP insertional mutation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[38]  R. Casareno,et al.  Brain Copper Content and Cuproenzyme Activity Do Not Vary with Prion Protein Expression Level* , 2000, The Journal of Biological Chemistry.

[39]  S. Warren,et al.  Aberrant Protein Deposition and Neurological Disease* , 1999, The Journal of Biological Chemistry.

[40]  S. Prusiner,et al.  Transmissible and genetic prion diseases share a common pathway of neurodegeneration , 1999, Nature.

[41]  A Helenius,et al.  Setting the standards: quality control in the secretory pathway. , 1999, Science.

[42]  F. Tagliavini,et al.  Sporadic Creutzfeldt-Jakob disease: Co-occurrence of different types of PrPSc in the same brain , 1999, Neurology.

[43]  I. Mcconnell,et al.  A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy , 1999, The EMBO journal.

[44]  K. Beyreuther,et al.  Prion protein-deficient neurons reveal lower glutathione reductase activity and increased susceptibility to hydrogen peroxide toxicity. , 1999, The American journal of pathology.

[45]  A. Aguzzi,et al.  Scrapie Pathogenesis in Subclinically Infected B-Cell-Deficient Mice , 1999, Journal of Virology.

[46]  F E Cohen,et al.  Protein misfolding and prion diseases. , 1999, Journal of molecular biology.

[47]  Inyoul Y. Lee,et al.  Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel. , 1999, Journal of molecular biology.

[48]  Fran Maher,et al.  The Hydrophobic Core Sequence Modulates the Neurotoxic and Secondary Structure Properties of the Prion Peptide 106‐126 , 1999, Journal of neurochemistry.

[49]  P. Lansbury,et al.  Amyloid diseases: abnormal protein aggregation in neurodegeneration. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[50]  S. Ferrari,et al.  Proteasomal Degradation and N-terminal Protease Resistance of the Codon 145 Mutant Prion Protein* , 1999, The Journal of Biological Chemistry.

[51]  John Collinge,et al.  Variant Creutzfeldt-Jakob disease , 1999, The Lancet.

[52]  D. Harris,et al.  Prion proteins carrying pathogenic mutations are resistant to phospholipase cleavage of their glycolipid anchors. , 1999, Biochemistry.

[53]  D. Perlmutter Misfolded proteins in the endoplasmic reticulum. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[54]  S. Prusiner,et al.  Prion protein conformation in a patient with sporadic fatal insomnia. , 1999, The New England journal of medicine.

[55]  R. Kaufman,et al.  Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. , 1999, Genes & development.

[56]  F. Cohen,et al.  Solution structure of Syrian hamster prion protein rPrP(90-231). , 1999, Biochemistry.

[57]  J. Ironside,et al.  Neuronal apoptosis in Creutzfeldt-Jakob disease. , 1999, Journal of neuropathology and experimental neurology.

[58]  F. Tagliavini,et al.  Microglial cells respond to amyloidogenic PrP peptide by the production of inflammatory cytokines. , 1999, Neuroreport.

[59]  R. Glockshuber,et al.  Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein. , 1999, Biochemistry.

[60]  G. Landreth,et al.  Identification of Microglial Signal Transduction Pathways Mediating a Neurotoxic Response to Amyloidogenic Fragments of β-Amyloid and Prion Proteins , 1999, The Journal of Neuroscience.

[61]  R. Wickner,et al.  Prions of Yeast and Fungi , 1999, The Journal of Biological Chemistry.

[62]  D. Harris,et al.  Copper Stimulates Endocytosis of the Prion Protein* , 1998, The Journal of Biological Chemistry.

[63]  B. Ghetti,et al.  Neurological Illness in Transgenic Mice Expressing a Prion Protein with an Insertional Mutation , 1998, Neuron.

[64]  W. Surewicz,et al.  Familial Mutations and the Thermodynamic Stability of the Recombinant Human Prion Protein* , 1998, The Journal of Biological Chemistry.

[65]  F. Cohen,et al.  Eight prion strains have PrPSc molecules with different conformations , 1998, Nature Medicine.

[66]  K Wüthrich,et al.  Prion protein NMR structure and familial human spongiform encephalopathies. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[67]  A. Giese,et al.  Role of Microglia in Neuronal Cell Death in Prion Disease , 1998, Brain pathology.

[68]  H. Budka,et al.  Neuronal Apoptosis in Fatal Familial Insomnia , 1998, Brain pathology.

[69]  R. Hegde,et al.  Regulation of protein topology by trans-acting factors at the endoplasmic reticulum. , 1998, Molecular cell.

[70]  B. Chesebro,et al.  Abnormal Properties of Prion Protein with Insertional Mutations in Different Cell Types* , 1998, The Journal of Biological Chemistry.

[71]  Christian von Mering,et al.  Expression of Amino-Terminally Truncated PrP in the Mouse Leading to Ataxia and Specific Cerebellar Lesions , 1998, Cell.

[72]  B. Chesebro,et al.  Scrapie infectivity found in resistant species , 1998, Nature.

[73]  S. Prusiner,et al.  A transmembrane form of the prion protein in neurodegenerative disease. , 1998, Science.

[74]  B. Chesebro BSE and Prions: Uncertainties About the Agent , 1998, Science.

[75]  G. Forloni,et al.  A Neurotoxic and Gliotrophic Fragment of the Prion Protein Increases Plasma Membrane Microviscosity , 1997, Neurobiology of Disease.

[76]  Shu G. Chen,et al.  Prion Protein Aggregation Reverted by Low Temperature in Transfected Cells Carrying a Prion Protein Gene Mutation* , 1997, The Journal of Biological Chemistry.

[77]  S. Prusiner,et al.  A hypothalamic neuronal cell line persistently infected with scrapie prions exhibits apoptosis , 1997, Journal of virology.

[78]  F E Cohen,et al.  A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform. , 1997, Journal of molecular biology.

[79]  H. Ushijima,et al.  Effect of Flupirtine on Bcl-2 and Glutathione Level in Neuronal Cells Treatedin Vitrowith the Prion Protein Fragment (PrP106-126) , 1997, Experimental Neurology.

[80]  A. Aguzzi,et al.  Bovine spongiform encephalopathy and early onset variant Creutzfeldt—Jakob disease , 1997, Current Opinion in Neurobiology.

[81]  K Wüthrich,et al.  NMR characterization of the full‐length recombinant murine prion protein, mPrP(23–231) , 1997, FEBS letters.

[82]  F. Cohen,et al.  Heritable disorder resembling neuronal storage disease in mice expressing prion protein with deletion of an α-helix , 1997, Nature Medicine.

[83]  J. Collinge,et al.  Mossy fibre reorganization in the hippocampus of prion protein null mice , 1997, Brain Research.

[84]  D. Harris,et al.  Identification of Intermediate Steps in the Conversion of a Mutant Prion Protein to a Scrapie-like Form in Cultured Cells* , 1997, The Journal of Biological Chemistry.

[85]  A. Rapak,et al.  Retrograde transport of mutant ricin to the endoplasmic reticulum with subsequent translocation to cytosol. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[86]  P. Lucassen,et al.  PrP Deposition, Microglial Activation, and Neuronal Apoptosis in Murine Scrapie , 1997, Experimental Neurology.

[87]  B. Chesebro,et al.  Prion protein and the transmissible spongiform encephalopathies. , 1997, Trends in cell biology.

[88]  J. Rossier,et al.  Transmission of the BSE Agent to Mice in the Absence of Detectable Abnormal Prion Protein , 1997, Science.

[89]  B. Kagan,et al.  Channel Formation by a Neurotoxic Prion Protein Fragment* , 1997, The Journal of Biological Chemistry.

[90]  S. Prusiner,et al.  Evidence for the Conformation of the Pathologic Isoform of the Prion Protein Enciphering and Propagating Prion Diversity , 1996, Science.

[91]  A. Aguzzi,et al.  Normal host prion protein (PrPC) is required for scrapie spread within the central nervous system. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[92]  S. Prusiner,et al.  Decreased receptor-mediated calcium response in prion-infected cells correlates with decreased membrane fluidity and IP sub 3 release , 1996, Neurology.

[93]  S. Prusiner,et al.  Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice. , 1996, Genes & development.

[94]  J Q Trojanowski,et al.  Molecular basis of phenotypic variability in sporadc creudeldt‐jakob disease , 1996, Annals of neurology.

[95]  D. Harris,et al.  Two mutant prion proteins expressed in cultured cells acquire biochemical properties reminiscent of the scrapie isoform. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[96]  R. Petersen,et al.  Effect of the D178N Mutation and the Codon 129 Polymorphism on the Metabolism of the Prion Protein (*) , 1996, The Journal of Biological Chemistry.

[97]  J. Collinge,et al.  Hippocampal slices from prion protein null mice: disrupted Ca2+-activated K+ currents , 1996, Neuroscience Letters.

[98]  P. Achermann,et al.  Altered circadian activity rhythms and sleep in mice devoid of prion protein , 1996, Nature.

[99]  T. Noda,et al.  Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene , 1996, Nature.

[100]  Bernhard Schmidt,et al.  Role of microglia and host prion protein in neurotoxicity of a prion protein fragment , 1996, Nature.

[101]  A. Aguzzi,et al.  Prion protein (PrP) with amino‐proximal deletions restoring susceptibility of PrP knockout mice to scrapie. , 1996, The EMBO journal.

[102]  M. Hoque,et al.  Experimental transmission of Creutzfeldt-Jakob disease and related diseases to rodents , 1996, Neurology.

[103]  A. Aguzzi,et al.  Normal host prion protein necessary for scrapie-induced neurotoxicity , 1996, Nature.

[104]  D. Harris,et al.  Mutant and Infectious Prion Proteins Display Common Biochemical Properties in Cultured Cells (*) , 1996, The Journal of Biological Chemistry.

[105]  H. Kretzschmar,et al.  Prion disease associated with a novel nine octapeptide repeat insertion in the PRNP gene. , 1995, Brain research. Molecular brain research.

[106]  D. Harris,et al.  A Mutant Prion Protein Displays an Aberrant Membrane Association When Expressed in Cultured Cells (*) , 1995, The Journal of Biological Chemistry.

[107]  R. Castellani,et al.  Regional distribution of protease‐resistant prion protein in fatal familial insomnia , 1995, Annals of neurology.

[108]  A. Giese,et al.  Neuronal Cell Death in Scrapie‐Infected Mice Is Due to Apoptosis , 1995, Brain pathology.

[109]  N. MacLeod,et al.  PrP gene dosage and long term potentiation. , 1995, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[110]  I. Mcconnell,et al.  PrP gene dosage determines the timing but not the final intensity or distribution of lesions in scrapie pathology. , 1994, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[111]  B. Ghetti,et al.  Amyloid fibrils in Gerstmann-Sträussler-Scheinker disease (Indiana and Swedish Kindreds) express only PrP peptides encoded by the mutant allele , 1994, Cell.

[112]  A. Aguzzi,et al.  High Prion and PrPSc Levels but Delayed Onset of Disease in Scrapie-Inoculated Mice Heterozygous for a Disrupted PrP Gene , 1994, Molecular medicine.

[113]  H. Kretzschmar,et al.  Mouse cortical cells lacking cellular PrP survive in culture with a neurotoxic PrP fragment , 1994, Neuroreport.

[114]  S. Prusiner,et al.  Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[115]  G. Forloni,et al.  A Neurotoxic Prion Protein Fragment Induces Rat Astroglial Proliferation and Hypertrophy , 1994, The European journal of neuroscience.

[116]  J. Ironside,et al.  Prion protein immunocytochemistry: reliable protocols for the investigation of Creutzfeldt–Jakob disease , 1994, Neuropathology and applied neurobiology.

[117]  M. Palmer,et al.  Prion protein is necessary for normal synaptic function , 1994, Nature.

[118]  S. Prusiner,et al.  Determinants of carboxyl-terminal domain translocation during prion protein biogenesis. , 1994, The Journal of biological chemistry.

[119]  M. Jeffrey,et al.  Murine scrapie-infected neurons in vivo release excess prion protein into the extracellular space , 1994, Neuroscience Letters.

[120]  P. Brown,et al.  Human spongiform encephalopathy: The national institutes of health series of 300 cases of experimentally transmitted disease , 1994, Annals of neurology.

[121]  R J Fletterick,et al.  Structural clues to prion replication. , 1994, Science.

[122]  G. Forloni,et al.  Conformational polymorphism of the amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. , 1994, The Journal of biological chemistry.

[123]  S. Prusiner,et al.  Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins , 1994, Cell.

[124]  R J Fletterick,et al.  Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[125]  S. Prusiner,et al.  Scrapie prions alter receptor‐mediated calcium responses in cultured cells , 1993, Neurology.

[126]  G. Forloni,et al.  Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. , 1993, Biochemical and biophysical research communications.

[127]  H. Ushijima,et al.  Cytoprotective effect of NMDA receptor antagonists on prion protein (PrionSc)-induced toxicity in rat cortical cell cultures. , 1993, European journal of pharmacology.

[128]  A. Aguzzi,et al.  Mice devoid of PrP are resistant to scrapie , 1993, Cell.

[129]  P. Lansbury,et al.  Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? , 1993, Cell.

[130]  A. Harding,et al.  Dementia associated with a 216 base pair insertion in the prion protein gene. Clinical and neuropathological features. , 1993, Brain : a journal of neurology.

[131]  G. Forloni,et al.  Neurotoxicity of a prion protein fragment , 1993, Nature.

[132]  L. Hood,et al.  Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. , 1993, Biochemistry.

[133]  S. Prusiner,et al.  Evidence for synthesis of scrapie prion proteins in the endocytic pathway. , 1992, The Journal of biological chemistry.

[134]  P. Brown,et al.  "Friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob disease , 1992, The Lancet.

[135]  S. Prusiner,et al.  Replication of distinct scrapie prion isolates is region specific in brains of transgenic mice and hamsters. , 1992, Genes & development.

[136]  S. Prusiner,et al.  Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein , 1992, Nature.

[137]  T. Crow,et al.  A dementing illness associated with a novel insertion in the prion protein gene. , 1992, Brain research. Molecular brain research.

[138]  G. J. Raymond,et al.  The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. , 1991, The Journal of biological chemistry.

[139]  S. Prusiner,et al.  Proteinase‐resistant prion protein accumulation in Syrian hamster brain correlates with regional pathology and scrapie infectivity , 1991, Neurology.

[140]  B. Caughey,et al.  Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. , 1991, Biochemistry.

[141]  H. Deng,et al.  Alterations in neurotransmitter-related enzyme activity in scrapie-infected PC12 cells. , 1991, The Journal of general virology.

[142]  H. Fraser,et al.  The disease characteristics of different strains of scrapie in Sinc congenic mouse lines: implications for the nature of the agent and host control of pathogenesis. , 1991, The Journal of general virology.

[143]  S. Prusiner,et al.  Spontaneous neurodegeneration in transgenic mice with mutant prion protein , 1990, Science.

[144]  Stephen J. DeArmond,et al.  Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication , 1990, Cell.

[145]  S. Prusiner,et al.  Differential release of cellular and scrapie prion proteins from cellular membranes by phosphatidylinositol-specific phospholipase C. , 1990, Biochemistry.

[146]  S. Prusiner,et al.  Scrapie prion proteins accumulate in the cytoplasm of persistently infected cultured cells , 1990, The Journal of cell biology.

[147]  S. Prusiner,et al.  Unusual topogenic sequence directs prion protein biogenesis. , 1990, Science.

[148]  S. Prusiner,et al.  Non-hydrophobic extracytoplasmic determinant of stop transfer in the prion protein , 1990, Nature.

[149]  Stephen J. DeArmond,et al.  Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques , 1989, Cell.

[150]  P. McBride,et al.  Precise targeting of the pathology of the sialoglycoprotein, PrP, and vacuolar degeneration in mouse scrapie , 1989, Neuroscience Letters.

[151]  B. Chesebro,et al.  Analyses of frequency of infection, specific infectivity, and prion protein biosynthesis in scrapie-infected neuroblastoma cell clones , 1988, Journal of virology.

[152]  S. Prusiner,et al.  Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins , 1988, Journal of virology.

[153]  S. Prusiner,et al.  Distinct prion proteins in short and long scrapie incubation period mice , 1987, Cell.

[154]  S. Prusiner,et al.  Changes in the localization of brain prion proteins during scrapie infection , 1987, Neurology.

[155]  S. Prusiner,et al.  Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene , 1986, Cell.

[156]  Ruedi Aebersold,et al.  A cellular gene encodes scrapie PrP 27-30 protein , 1985, Cell.

[157]  L. Hood,et al.  Purification and structural studies of a major scrapie prion protein , 1984, Cell.

[158]  S. Prusiner Novel proteinaceous infectious particles cause scrapie. , 1982, Science.

[159]  J. Griffith,et al.  Nature of the Scrapie Agent: Self-replication and Scrapie , 1967, Nature.

[160]  TIKVAH ALPER,et al.  Does the Agent of Scrapie Replicate without Nucleic Acid ? , 1967, Nature.

[161]  D. Gajdusek,et al.  Degenerative disease of the central nervous system in New Guinea; the endemic occurrence of kuru in the native population. , 1957, The New England journal of medicine.

[162]  A. Chong,et al.  Onset of accumulation of PrPres in murine ME7 scrapie in relation to pathological and PrP immunohistochemical changes. , 2001, Journal of comparative pathology.

[163]  J. Collinge Prion diseases of humans and animals: their causes and molecular basis. , 2001, Annual review of neuroscience.

[164]  D. Riesner,et al.  Neurotoxicity but not infectivity of prion proteins can be induced reversibly in vitro. , 2000, Archives of virology. Supplementum.

[165]  S. DeArmond,et al.  14 Neuropathology of Prion Diseases , 1999 .

[166]  J. Bonifacino,et al.  Ubiquitin and the control of protein fate in the secretory and endocytic pathways. , 1998, Annual review of cell and developmental biology.

[167]  Michael Wall,et al.  Friendly Fire , 1998 .

[168]  F E Cohen,et al.  Pathologic conformations of prion proteins. , 1998, Annual review of biochemistry.

[169]  P. Walter,et al.  Intracellular signaling from the endoplasmic reticulum to the nucleus. , 1998, Annual review of cell and developmental biology.

[170]  R. Carp,et al.  Brain regional distribution of prion protein PrP27-30 in mice stereotaxically microinjected with different strains of scrapie. , 1993, The Journal of infectious diseases.

[171]  A. Helenius,et al.  Protein oligomerization in the endoplasmic reticulum. , 1989, Annual review of cell biology.